Costopoulos Mark DPM is categorized under Podiatrists in Los Angeles, CA and active since 1981.
Costopoulos Mark DPM was established in 1981, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Podiatrists business, which does work in the B2C market, and is classified as a Podiatrists, under code number 6213910 by the NAICS.
If you are seeking more information, feel free to contact Mark Costopoulos at the company’s single location by writing to 6333 Wilshire Boulevard # 304, Los Angeles, California CA 90048 or by phoning (323) 933-7548. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Costopoulos Mark DPM |
| Contact Person: | Mark Costopoulos |
| Address: | 6333 Wilshire Boulevard # 304, Los Angeles, California 90048 |
| Phone Number: | (323) 933-7548 |
| Website Address: | bcfootcare.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1981 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Podiatrists |
| SIC Code: | 8043 |
| NAICS Code: | 6213910 |
| Share This Business: |
Costopoulos Mark DPM was started in 1981 to provide professional Podiatrists under the SIC code 8043 and NAICS code 6213910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mark Costopoulos for inquiries that concern Costopoulos Mark DPM by calling the company number (323) 933-7548, as your correspondence is most welcome. Additionally, the physical location of the single location of Costopoulos Mark DPM can be found at the coordinates 34.063541,-118.366327 as well as the street address 6333 Wilshire Boulevard # 304 in Los Angeles, California 90048.
For its online presence, you may visit Costopoulos Mark DPM’s website at bcfootcare.com and engage with its social media outlets through on Twitter and on Facebook.